Russell Watts

753 total citations
16 papers, 582 citations indexed

About

Russell Watts is a scholar working on Molecular Biology, Epidemiology and Biochemistry. According to data from OpenAlex, Russell Watts has authored 16 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Biochemistry. Recurrent topics in Russell Watts's work include Lipid metabolism and biosynthesis (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholesterol and Lipid Metabolism (3 papers). Russell Watts is often cited by papers focused on Lipid metabolism and biosynthesis (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholesterol and Lipid Metabolism (3 papers). Russell Watts collaborates with scholars based in Canada, United States and Saudi Arabia. Russell Watts's co-authors include Richard Lehner, David Allan, Robert H. Michell, Jihong Lian, Jean E. Vance, Emily M. Lynes, Matthew D. Benson, Thomas Simmen, Randal C. Nelson and Lena Li and has published in prestigious journals such as Scientific Reports, Neuroscience and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Russell Watts

16 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell Watts Canada 11 295 162 152 151 112 16 582
Su Sung Kim South Korea 9 274 0.9× 248 1.5× 111 0.7× 164 1.1× 169 1.5× 13 662
Melissa A. Greeve Australia 7 461 1.6× 145 0.9× 127 0.8× 189 1.3× 62 0.6× 8 778
Ying Leng China 10 392 1.3× 88 0.5× 90 0.6× 231 1.5× 118 1.1× 19 575
Sabine Daemen Netherlands 15 335 1.1× 284 1.8× 160 1.1× 328 2.2× 96 0.9× 19 893
Tianluo Lei China 12 307 1.0× 101 0.6× 128 0.8× 146 1.0× 85 0.8× 16 622
Camila Martínez Calejman Argentina 13 294 1.0× 131 0.8× 84 0.6× 290 1.9× 65 0.6× 22 653
Wanli Cheng United States 6 425 1.4× 117 0.7× 82 0.5× 199 1.3× 162 1.4× 9 734
Vera Lemos Switzerland 10 334 1.1× 252 1.6× 73 0.5× 216 1.4× 92 0.8× 10 742
Brian M. Wiczer United States 12 553 1.9× 149 0.9× 70 0.5× 298 2.0× 103 0.9× 15 850
Kezhi Dai United States 13 335 1.1× 169 1.0× 137 0.9× 54 0.4× 105 0.9× 20 708

Countries citing papers authored by Russell Watts

Since Specialization
Citations

This map shows the geographic impact of Russell Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Watts more than expected).

Fields of papers citing papers by Russell Watts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Watts. The network helps show where Russell Watts may publish in the future.

Co-authorship network of co-authors of Russell Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Watts. A scholar is included among the top collaborators of Russell Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Watts. Russell Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Leonard, Kelly‐Ann, Randal C. Nelson, Russell Watts, et al.. (2025). Alterations in phosphatidylethanolamine metabolism impacts hepatocellular lipid storage, energy homeostasis, and proliferation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1870(4). 159608–159608. 2 indexed citations
2.
Wang, Haizhen, Özlem Tufanlı, Yong Yu, et al.. (2024). FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver. Molecular Metabolism. 90. 102048–102048. 5 indexed citations
3.
Watts, Russell, et al.. (2023). Preferential lipolysis of DGAT1 over DGAT2 generated triacylglycerol in Huh7 hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(10). 159376–159376. 8 indexed citations
4.
Hussain, Aashiq, Jihong Lian, Russell Watts, et al.. (2022). Attenuation of obesity-induced hyperlipidemia reduces tumor growth. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(4). 159124–159124. 7 indexed citations
5.
Lian, Jihong, Jelske N. van der Veen, Russell Watts, René L. Jacobs, & Richard Lehner. (2021). Carboxylesterase 1d (Ces1d) does not contribute to cholesteryl ester hydrolysis in the liver. Journal of Lipid Research. 62. 100093–100093. 10 indexed citations
6.
Lian, Jihong, Russell Watts, Ariel D. Quiroga, et al.. (2019). Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation. Journal of Lipid Research. 60(4). 880–891. 17 indexed citations
7.
Lian, Jihong, Randal C. Nelson, Lena Li, et al.. (2018). Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(7). 688–699. 25 indexed citations
8.
Diané, Abdoulaye, Richard Lehner, Russell Watts, et al.. (2018). Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model. American Journal of Physiology-Endocrinology and Metabolism. 316(1). E16–E33. 27 indexed citations
9.
Sakamuri, Siva S. V. P., Russell Watts, Abhijit Takawale, et al.. (2017). Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption. Scientific Reports. 7(1). 6210–6210. 35 indexed citations
10.
Watts, Russell, et al.. (2016). Liver-specific expression of carboxylesterase 1g/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(5). 482–490. 21 indexed citations
11.
Lian, Jihong, En‐Hui Wei, Jody Groenendyk, et al.. (2016). Ces3/TGH Deficiency Attenuates Steatohepatitis. Scientific Reports. 6(1). 25747–25747. 36 indexed citations
12.
Li, Chen, Lena Li, Jihong Lian, et al.. (2015). Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes. Arteriosclerosis Thrombosis and Vascular Biology. 35(5). 1080–1091. 69 indexed citations
13.
Webber, Christine A., George Luu, Shaona Acharjee, et al.. (2013). Nerve growth factor acts through the TrkA receptor to protect sensory neurons from the damaging effects of the HIV-1 viral protein, Vpr. Neuroscience. 252. 512–525. 21 indexed citations
14.
Lynes, Emily M., et al.. (2010). Ero1α requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM). Cell Stress and Chaperones. 15(5). 619–629. 153 indexed citations
15.
MacDonald, Marcia L.E., Roshni R. Singaraja, Nagat Bissada, et al.. (2007). Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice. Journal of Lipid Research. 49(1). 217–229. 53 indexed citations
16.
Allan, David, Russell Watts, & Robert H. Michell. (1976). Production of 1,2-diacylglycerol and phosphatidate in human erythrocytes treated with calcium ions and ionophore A23187. Biochemical Journal. 156(2). 225–232. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026